{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:34:50Z","timestamp":1785803690530,"version":"3.56.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T00:00:00Z","timestamp":1592092800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clim.2020.108443","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T14:35:37Z","timestamp":1587998137000},"page":"108443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["ADA2 deficiency complicated by EBV-driven lymphoproliferative disease"],"prefix":"10.1016","volume":"215","author":[{"given":"Emily","family":"Staples","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Simeoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana Lango","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Graham","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Javid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effrossyni","family":"Gkrania-Klotsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gattens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Firth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Shamardina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri V.V.","family":"Deevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matina","family":"Prapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Uttenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinakantha","family":"Kumararatne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.D.","family":"Thaventhiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2020.108443_bb0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10875-015-0198-5","article-title":"The 2015 IUIS phenotypic classification for primary Immunodeficiencies","volume":"35","author":"Bousfiha","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108443_bb0010","first-page":"431544","article-title":"GRID - Genomics of Rare Immune Disorders: a highly sensitive and specific diagnostic gene panel for patients with primary immunodeficiencies","author":"Simeoni","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.clim.2020.108443_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-016-0111-7","article-title":"Monogenic polyarteritis: the lesson of ADA2 deficiency","author":"Caorsi","year":"2016","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.clim.2020.108443_bb0020","article-title":"Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa","author":"Santiago","year":"2015","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.clim.2020.108443_bb0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.clim.2020.108443_bb0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20161846","article-title":"Human immunity against EBV\u2014lessons from the clinic","volume":"214","author":"Tangye","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2020.108443_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.03.002","article-title":"Immunodeficiency and Epstein Barr virus induced lymphoproliferation caused by 4-1BB deficiency","author":"Alosaimi","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108443_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee","author":"Tangye","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108443_bb0045","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/art.40147","article-title":"Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood","volume":"69","author":"Schepp","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2020.108443_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/BJ20050683","article-title":"Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity","volume":"391","author":"Zavialov","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.clim.2020.108443_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.01.012","article-title":"ADA2 deficiency: clonal lymphoproliferation in a subset of patients","volume":"141","author":"Trotta","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108443_bb0060","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/clinchem\/38.7.1322","article-title":"Serum adenosine deaminase: isoenzymes and diagnostic application","volume":"38","author":"Ungerer","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clim.2020.108443_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2020.108443_bb0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.2018892752","article-title":"Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2","volume":"134","author":"Carmona-Rivera","year":"2019","journal-title":"Blood"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620300346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620300346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:03:39Z","timestamp":1761494619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661620300346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":14,"alternative-id":["S1521661620300346"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2020.108443","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADA2 deficiency complicated by EBV-driven lymphoproliferative disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2020.108443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108443"}}